Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Vanguard Real Estate ETF
VNQ
$39.2B
| $2.32M | ﹤0.01% |
+25,000
| New | +$2.32M |
|
|
RC
2252
Ready Capital
RC
$306M
| $2.32M | ﹤0.01% |
150,345
+132,100
| +724% | +$2.08M |
|
2253
TC Energy
TRP
$66.7B
| $2.31M | ﹤0.01% |
43,403
-120,097
| -73% | -$6.16M |
|
2254
Coherus Oncology
CHRS
$185M
| $2.31M | ﹤0.01% |
+128,000
| New | +$2.36M |
|
|
AIOT
2255
PowerFleet Inc
AIOT
$417M
| $2.3M | ﹤0.01% |
353,310
+36,173
| +11% | +$218K |
|
|
CNSL
2256
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $2.3M | ﹤0.01% |
592,903
+579,103
| +4,196% | +$2.22M |
|
|
MBCN
2257
DELISTED
Middlefield Banc Corp
MBCN
| $2.3M | ﹤0.01% |
88,012
+3,594
| +4% | +$88.3K |
|
2258
Century Aluminum
CENX
$4.62B
| $2.29M | ﹤0.01% |
+304,999
| New | +$2.11M |
|
|
PVBC
2259
DELISTED
Provident Bancorp
PVBC
| $2.29M | ﹤0.01% |
184,077
+148,528
| +418% | +$1.75M |
|
|
SDRL
2260
DELISTED
Seadrill Limited Common Stock
SDRL
| $2.29M | ﹤0.01% |
902,300
+331,600
| +58% | +$549K |
|
|
DAY
2261
DELISTED
Dayforce
DAY
| $2.29M | ﹤0.01% |
33,700
+25,300
| +301% | +$1.4M |
|
|
MLVF
2262
DELISTED
Malvern Bancorp, Inc.
MLVF
| $2.29M | ﹤0.01% |
98,952
+21,400
| +28% | +$484K |
|
|
HEXO
2263
DELISTED
HEXO Corp. Common Shares
HEXO
| $2.28M | ﹤0.01% |
25,563
+24,938
| +3,990% | +$3.28M |
|
|
TLRD
2264
DELISTED
Tailored Brands, Inc.
TLRD
| $2.28M | ﹤0.01% |
+550,350
| New | +$2.59M |
|
|
SVC
2265
Service Properties Trust
SVC
$1.05B
| $2.27M | ﹤0.01% |
18,700
-126,380
| -87% | -$15.4M |
|
|
SNT
2266
Senstar Technologies
SNT
$42.9M
| $2.27M | ﹤0.01% |
606,376
+51,300
| +9% | +$205K |
|
2267
Resideo Technologies
REZI
$3.1B
| $2.27M | ﹤0.01% |
+190,200
| New | +$2.16M |
|
2268
Strategy Inc
MSTR
$36.6B
| $2.27M | ﹤0.01% |
158,850
-92,970
| -37% | -$1.38M |
|
|
HMNF
2269
DELISTED
HMN Financial Inc
HMNF
| $2.26M | ﹤0.01% |
107,700
+800
| +0.7% | +$16.9K |
|
|
VOXX
2270
DELISTED
VOXX International Corporation Class A
VOXX
| $2.26M | ﹤0.01% |
516,122
+64,079
| +14% | +$296K |
|
2271
Mercury Systems
MRCY
$6.67B
| $2.25M | ﹤0.01% |
32,635
-102,800
| -76% | -$7.41M |
|
|
ODP
2272
DELISTED
ODP
ODP
| $2.24M | ﹤0.01% |
81,907
-298,240
| -78% | -$6.64M |
|
2273
Eagle Bancorp Montana
EBMT
$187M
| $2.24M | ﹤0.01% |
104,526
+44,494
| +74% | +$878K |
|
2274
Jakks Pacific
JAKK
$294M
| $2.23M | ﹤0.01% |
216,468
+3,520
| +2% | +$31.3K |
|
2275
Amalgamated Financial
AMAL
$1.53B
| $2.23M | ﹤0.01% |
114,585
+42,285
| +58% | +$779K |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.